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Background: Chungsimyeonja-eum (CSYJE) is an herbal prescription used in traditional Oriental medicine for
treating cerebral infarction by reducing ischemic damage. However, the effects of CSYJE on inflammation have
not been verified scientifically.
Methods: Anti-inflammatory effects of CSYJE was investigated to dertermine the inhibitory effects of CSYJE against
inflammation using RAW 264.7 mouse macrophages and HaCaT human keratinocytes. To measure the effects of
CSYJE on inflammatory mediators and cytokines/chemokines, we used the following methods: cell viability assay,
enzyme-linked immunosorbent assay (ELISA), western blotting, immunocytochemistry. RAW 264.7 cells were
pretreated with CSYJE (250, 500, or 1000 μg/mL) for 4 h and treated with lipopolysaccharide (LPS) for additional
20 h. HaCaT cells were stimulated with tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ) (TI), and
CSYJE (125, 250, or 500 μg/mL) for 24 h.
Results: CSYJE suppressed the production of nitric oxide (NO, IC50 1000 μg/mL), prostaglandin E2 (PGE2, IC50 =
12.1 μg/mL), and interleukin (IL)-6 (IC50 = 248 μg/mL) in LPS-stimulated RAW 264.7 cells. CSYJE suppressed the
effects of TI on the production of thymus and activation-regulated chemokine (TARC, IC50 = 330.2 μg/mL),
macrophage-derived chemokine (MDC/CCL22, IC50 = 52.5 μg/mL), regulated on activation, normal T-cell expressed
and secreted (RANTES/CCL5, IC50 = 372.9 μg/mL), and IL-8 (IC50 = 345.1 μg/mL) in HaCaT cells. CSYJE inhibited TI-
stimulated STAT1 phosphorylation in a dose-dependent manner and nuclear translocation at 500 μg/mL in HaCaT
cells.
Conclusion: Our results suggest a possible therapeutic application of CSYJE for treating inflammatory diseases.
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Inflammation constitutes multiple processes, character-
ized by the infiltration of inflammatory cells, such as
Th2-type cells, eosinophils, mast cells, and macrophages.
Of these activated cells, macrophages play a central role
in managing many different pathological immune phe-
nomena such as the over-production of inflammatory
mediators. Various mediators, such as nitric oxidase,* Correspondence: sjijeong@kiom.re.kr
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(http://creativecommons.org/publicdomain/zeprostaglandins, and inflammatory cytokines such as inter-
leukin (IL)-6, IL-1β and tumor necrosis factor (TNF)-α,
and others induced by macrophages have important roles
in inflammatory diseases [1–3].
Migration of inflammatory cells is regulated by chemo-
kines. These are small proteins released from various cell
types, which regulate the traffic of immune cells to site of
inflammation or infection. Various inflammatory cytokines
stimulate the expression of inflammatory chemokines
[4, 5]. Among them, thymus and activation-regulated
chemokine (TARC/CCL17), macrophage-derived chemo-
kine (MDC/CCL22), and regulated on activation, normal
T-cell expressed and secreted (RANTES/CCL5) are typicaldistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Lim et al. BMC Complementary and Alternative Medicine  (2015) 15:371 Page 2 of 9inflammatory chemokines and ligands for CC chemokine
receptor 4 (CCR4), which is predominantly expressed on
keratinocytes, Th2 lymphocytes, and basophils [6, 7]. In
addition, IL-8 is another inflammatory mediator involved
in allergic responses that is closely associated with the
severity of chronic inflammation [8].
Extracellular binding of cytokines induces activation
of the intracellular Janus kinase (JAK) that phosphory-
lates a specific tyrosine residue in signal transducer and
activator of transcription (STAT) proteins [9], which are
involved in the development and function of the immune
system [10]. There are seven mammalian STAT family
members that have been identified: STAT1, STAT2,
STAT3, STAT4, STAT5 (STAT5A and STAT5B) and
STAT6. In particular, STAT1 is a crucial molecule for the
interferon (IFN)/cytokine-signaling pathways [11]. Thus,
IFN-γ stimulates JAK phosphorylation, which in turn
induces STAT1 phosphorylation [12]. These events even-
tually increase the production of chemokines including
TARC, MDC, and RANTES [13, 14].
The traditional herbal formula Chungsimyeonja-eum
(CSYJE) comprises nine medicinal herbs and has trad-
itionally been used in the treatment of heart and brain
diseases in Oriental medicine. Previous research reported
that the water extract of CSYJE has cytoprotective
effect against glutamate-induced C6 glial cell death
[15]. Other studies showed that CSYJE protects against
ischemic stroke and has anti-stress activity [16, 17].
However, there has been no investigation focusing on
the inflammatory effects of CSYJE. Therefore, we in-
vestigated the effects and action mechanisms of CSYJE
on the inflammatory mediators in RAW 264.7 macro-
phages and HaCaT keratinocytes.
Methods
Preparation of CSYJE water extract
The 9 crude herbal medicines forming CSYJE were
purchased from Kwangmyungdang Medicinal Herbs
(Ulsan, Korea). The origin of 9 herbal medicines wasTable 1 Herbal composition of a single dose of CSYJE
Latin name Scientific name
Nelumbinis Semen Nelumbo nucifera Gaerhner
Poria Sclerotium Poria cocos Wolf
Ginseng Radix Panax ginseng C. A. Meyer
Astragali Radix Astragalus membranaceus Bu
Scutellariae Radix Scutellaria baicalensis Georgi
Plantaginis Semen Plantago asiatica L.
Liriope Tuber Liriope platyphylla Wang et T
Lycii Radicis Cortex Lycium chinense Miller
Glycyrrhizae Radix et Rhizoma Glycyrrhiza uralensis Fischer
Totalconfirmed taxonomically by Professor Je-Hyun Lee, Dong-
guk University, Gyeongju, Republic of Korea. A voucher
specimen (2012–KE43–1 ~ KE43–9) has been deposited
at K-herb Research Center, Korea Institute of Oriental
Medicine. For preparation of CSYJE water decoction, each
herbal medicine was mixed as Table 1 (total weight =
5.0 kg, about 156.9 times of composition of single dose)
and extracted in distilled water at 100 °C for 2 h under
pressure (98 kPa) using an electric extractor (COSMOS-
660; Kyungseo Machine Co., Incheon, Korea). The extract
solution was filtrated using a standard sieve (No. 270,
53 μm; Chung Gye Sang Gong Sa, Seoul, Korea) and
freeze-dried to give a powder sample. The yield of CSYJE
extract was 13.0 % (651.4 g).
High-performance liquid chromatography (HPLC) analysis
of CSYJE
Quantitative analysis of the CSYJE sample was performed
using a Shimadzu LC-20A Prominence HPLC system
(Shimadzu Co., Kyoto, Japan) consisting of a solvent deliv-
ery unit, an on-line degasser, a column oven, an autosam-
pler, and a photo diode array (PDA) detector. The data
were acquired and processed by LabSolution software
(Version 1.24 SP1). A SunFire C18 column (250 × 4.6 mm;
particle size 5 μm, Waters, Milford, MA, USA), which was
maintained at 40 °C, was used as the stationary phase and
the mobile phases were consisted of 0.1 % (v/v) formic
acid in water (A) and 0.1 % (v/v) formic acid in acetonitrile
(B). The elution conditions were as follows: 10–60 %
B for 0–30 min, 60–100 % B for 30–40 min, 100 % B
for 40–45 min, and 100–10 % B for 45–50 min. The
flow-rate was 1.0 mL/min and injection volume was
10 μL. For HPLC analysis of CSYJE, lyophilized 200 mg
of CSYJE extract was dissolved in 20 mL of distilled water
and then the solution was diluted to 10-fold for quantita-
tive analysis of baicalin and wogonoside. Each solution
was filtered through a SmartPor GHP 0.2 μm syringe
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Murine macrophage RAW 264.7 and human keratinocyte
HaCaT were obtained from the American Type Culture
Collection (Rockville, MD) and CLS Cell Lines Service
GmbH (Eppelheim, Baden-Württemberg, Germany), re-
spectively. The cells were cultured in Dulbecco’s modified
Eagle’s medium (Gibco Inc., Grand Island, NY) supple-
mented with 5.5 % (for RAW 264.7) or 10 % (for HaCaT)
heat-inactivated fetal bovine serum (Gibco Inc.), penicillin
(100 U/mL), and streptomycin (100 μg/mL) in a 5 % CO2
incubator at 37 °C.Cytotoxicity assay
Cell viability was assessed using a Cell Counting Kit-8
assay (CCK-8 from Dojindo, Kumamoto, Japan) ac-
cording to the manufacturer’s instructions. RAW
264.7 cells (3 × 103 cells/well) and HaCaT cells (1 ×
103 cells/well) were incubated in 96-well plates with
various concentrations of the CSYJE for 24 h. The
CCK-8 reagent was added to each well, followed by
incubation for an additional 4 h, and the absorbance
was measured at 450 nm using a Benchmark plus mi-
croplate reader (Bio-Rad Laboratories, Hercules, CA).
The percentage of viable cells was calculated using
the following equation: cell viability (%) = (mean absorb-
ance in test well/mean absorbance in control well) ×
100.Measurement of nitric oxide (NO), prostaglandin E2
(PGE2), and IL-6 production
RAW 264.7 cells were plated at a density of 2.5 × 105
cells/well in 48-well plates and incubated overnight.
Cells were pretreated with various concentrations of
CSYJE for 4 h and then treated with LPS (1 μg/mL) for
an additional 20 h. The supernatants were collected and
analyzed for the levels of NO (Griess Reagent System;
Promega Corp., Madison, WI), and PGE2 and IL-6
using enzyme-linked immunosorbent assay (ELISA) kits
(Cayman Chemical Co., Ann Arbor, MI for PGE2, and
R&D Systems, Minneapolis, MN) according to the manu-
facturers’ protocols.Measurement of chemokine production
HaCaT cells (1 × 106 cells/well) were cultured in 6-
well plates. After reaching confluency, the cells were
washed and treated with CSYJE in 1 mL of serum-
free medium containing tumor necrosis factor-α (TNF-α)
and interferon-γ (IFN-γ) (TI, each 10 ng/mL; R&D Sys-
tems Inc., Minneapolis, MN, USA) for 24 h. The produc-
tion of TARC, MDC, RANTES, and IL-8 was determined
using commercial ELISA kits (R&D Systems Inc.).Western blotting
HaCaT cells were treated with a nontoxic concentra-
tion of CSYJE for 1 h, and then incubated in the
presence of TI for 30 min. The cells were collected
by centrifugation, washed twice with PBS, and sus-
pended in an extraction lysis buffer (Sigma-Aldrich,
St. Louis, MO) containing protease inhibitors. The
protein concentration was determined using a protein
assay reagent (Bio-Rad Laboratories, Hercules, CA)
according to the manufacturer’s instructions. Equal
amounts of total protein (30 μg) were resolved by 10
% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred to a nitrocellu-
lose membrane. The membrane was incubated with
blocking solution [5 % skim milk in Tris-buffered
saline containing Tween 20 (TBST)], followed by an
overnight incubation at 4 °C with the appropriate
primary antibody. The following primary antibodies
and dilution were used: anti-β-actin (1:1000 dilution;
Cell Signaling, Danvers, MA), anti-STAT1, and anti-
phospho-STAT1 (1:1000 dilution; Abcam, Cambridge,
UK). The membranes were washed three times with
TBST, and then incubated with a 1:3000 dilution of a
horseradish peroxidase (HRP)-conjugated secondary
antibody (Jackson ImmunoResearch, West Grove, PA)
for 1 h at room temperature. The membranes were
again washed three times with TBST, and then devel-
oped using an enhanced chemiluminescence (ECL) kit
(Thermo scientific, Rockford, IL). Image capture was
performed using Chemi-Doc (Bio-Rad).Immunofluorescence staining
HaCaT cells were seeded onto glass coverslips and
incubated with TI in the absence or presence of
CSYJE (500 μg/mL) for 30 min. The cells were fixed
in 4 % paraformaldehyde and 100 % acetone, blocked
in 0.5 % bovine serum albumin, and incubated with
anti-STAT1 antibody (Cell Signaling, Danvers, MA)
for 1 h at room temperature. Then, fluorescein iso-
thiocyanate (FITC)-conjugated anti-rabbit immuno-
globulin G (IgG) antibody (Invitrogen, Carlsbad, CA)
was used as a secondary antibody. The immuno-
stained cells were mounted with medium containing
4′6-diamidino-2-phenylindole (DAPI) and visualized
using an Olympus FLUOVIEW FV10i confocal micro-
scope (Tokyo, Japan).Statistical analysis
The data are expressed as the mean ± SEM. Data were
analyzed using one-way analysis of variance and
Dunnett’s multiple comparisons test. Results with a
P value < 0.05 were considered to be statistically
significant.
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Identification and quantification of the marker
components in CSYJE
Calibration curves of the five marker components
showed good linearity with correlation coefficient (r2) ≥
0.9998 in the different concentration ranges. Using opti-
mized chromatography conditions, Three-dimensional
chromatogram was obtained using HPLC–PDA detector
and the five marker compounds were eluted within
35 min (Fig. 1). The amounts of the five marker
compounds, liquiritin apioside, liquiritin, baicalin,
wogonoside, and glycyrrhizin, were 1.43 ± 0.02, 2.00 ±
0.03, 22.52 ± 0.36, 7.11 ± 0.02, and 2.49 ± 0.02 mg/g,
respectively.Effects of CSYJE on cell viability of RAW 264.7 mouse
macrophages and HaCaT human keratinocytes
To examine the effect of CSYJE on cell viability, RAW
264.7 cells and HaCaT cells were treated with various
concentration ranging from 250 to 1000 μg/mL and 125
to 500 μg/mL of CSYJE for 24 h, respectively. As shown
in Fig. 2, the survival of RAW 264.7 cells and HaCaT
cells were not affected by exposure to concentration of
CSYJE compared to that of the controls. Therefore,
nontoxic concentrations (250, 500, or 1000 μg/mL inFig. 1 Three-dimensional chromatogram of CSYJE by HPLC-PDA. The reten
baicalin, wogonoside, and glycyrrhizin, were appeared at approximately 13RAW 264.7 cells; 125, 250, or 500 μg/mL in HaCaT cells)
of CSYJE were used for the subsequent experiments.CSYJE inhibits production of pro-inflammatory mediators
in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells
To determine the effects of CSYJE on NO and PGE2
production following LPS stimulation, RAW 264.7 cells
were pretreated with various concentrations of CSYJE
(0, 250, 500, or 1000 μg/mL) for 4 h and then stimulated
with LPS (1 μg/mL) for an additional 20 h. CSYJE
suppressed LPS-stimulated NO production in a dose-
dependent manner (Fig. 3a). LPS significantly stimulated
NO production by RAW 264.7 cells (14.42 ± 0.24 μM).
By contrast, CSYJE significantly decreased NO produc-
tion to 9.67 ± 0.09 μM (P < 0.01) at 500 μg/mL and to
5.76 ± 0.15 μM (P < 0.01) at a dose of 1000 μg/mL. PGE2
production was higher in LPS-stimulated RAW 264.7
cells than in untreated control cells, whereas CSYJE
dose-dependently inhibited PGE2 production by LPS
stimulation (Fig. 3b). Furthermore, LPS treatment dra-
matically increased IL-6 level up to 123.96 ng/mL
compared with untreated control. In contrast, CSYJE
significantly inhibited IL-6 production by 54.82, 55.31,
and 66.89 % at 250, 500, and 1000 μg/mL, respectively
(Fig. 3c).tion times of the five marker compounds, liquiritin apioside, liquiritin,
.86, 14.26, 20.00, 23.18, and 28.51 min, respectively
Fig. 2 Cytotoxicity of CSYJE against RAW 264.7 cells or HaCaT cells. RAW 264.7 (a) or HaCaT (b) cells were seeded onto 96-well plates and treated
with various concentrations of CSYJE for 24 h. Cell viability (%) was assessed using a CCK-8 assay. The values are expressed as the mean ± SEM of
three independent experiments
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IFN-γ-stimulated HaCaT cells
The effects of CSYJE on TARC, MDC, RANTES, and
IL-8 production levels were assessed in TI-stimulated
HaCaT cells. As shown in Fig. 4a, HaCaT cells treated
with TI increased the TARC level (10.78 ± 1.21 ng/mL,Fig. 3 Effects of CSYJE on LPS-stimulated production of pro-inflammatory m
were measured in the culture supernatants from cells treated with CSYJE a
4 h and LPS (1 μg/mL) for additional 20 h for NO, PGE2, and IL-6 assays. Ce
IL-6 assays, and 15.625, 31.25, 62.5, 125, 250, 500, or 1000 μg/mL for PGE2 a
L-N-methylarginine (L-NMMA; (100 μM) and indomethacin (2.5 ng/mL) wer
from three independent experiments. ##P < 0.01 vs vehicle control cells; andP < 0.01) compared with the vehicle-treated cells (0.65 ±
0.18 ng/mL). By contrast, CSYJE suppressed TI-stimulated
TARC production in a dose-dependent manner. The
levels were reduced by 6.44 ± 0.35 ng/mL (P < 0.01)
and 1.88 ± 0.45 ng/mL (P < 0.01) using 250 and 500 μg/
mL, respectively. MDC production in TI-treated cellsediators in RAW 264.7 cells. Levels of NO (a), PGE2 (b), and IL-6 (c)
nd LPS. Cells were pretreated with CSYJE (250, 500, or 1000 μg/mL) for
lls were pretreated with CSYJE (250, 500, or 1000 μg/mL for NO and
ssay) for 4 h and LPS (1 μg/mL) for additional 20 h for PGE2 assay.
e used as positive control drugs. The bar graphs represent the means
**P < 0.01 vs LPS-treated cells
Fig. 4 Effects of CSYJE on TNF-α and IFN-γ-stimulated productions of chemokines in HaCaT cells. Levels of TARC (a), MDC (b), RANTES (c), and
IL-8 (d) were measured using the culture supernatants from cells treated with CSYJE (125, 250, or 500 μg/mL), and TNF-α and IFN-γ (each 10 ng/mL, TI)
for 24 h. Silymarin (6.25, 12.5, or 25 μg/mL) was used as a positive control. Values were expressed as mean ± SEM of three independent experiments.
##P < 0.01 vs vehicle control cells; and **P < 0.01 vs TI-treated cells
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pared with vehicle-treated cells, but the levels were re-
duced significantly after treatment with CSYJE treatment
(205.25 ± 16.80 ng/mL at 125 μg/mL, P < 0.01; 74.15 ±
11.59 ng/mL at 250 μg/mL, P < 0.01; and 24.34 ± 4.69 ng/
mL at 500 μg/mL, P < 0.01) (Fig. 4b). TI-treated cells pro-
duced significantly more RANTES (1019.80 ± 66.97 ng/
mL, P < 0.01) compared with the vehicle-treated cells. The
TI-induced increase in RANTES production was sig-
nificantly inhibited by CSYJE (644.18 ± 29.79 ng/mL at
250 μg/mL, P < 0.01; and 319.94 ± 68.15 ng/mL at 500 μg/
mL, P < 0.01) (Fig. 4c). In addition, the level of IL-8
(2848.74 ± 98.83 ng/mL, P < 0.01) was also significantly
reduced by CSYJE in a dose-dependent manner (1648.33 ±
56.81 ng/mL at 250 μg/mL, P < 0.01; and 1126.23 ±
38.02 ng/mL at 500 μg/mL, P < 0.01) (Fig. 4d). The inhibi-
tory effects of CSYJE were similar to those of silymarin,
which was used as a positive control.
CSYJE inhibits STAT1 phosphorylation in TNF-α and
IFN-γ-stimulated HaCaT cells
TI-stimulated HaCaT cells showed markedly increased
STAT1 phosphorylation compared with non-stimulated
HaCaT cells. Treatment with silymarin reduced the levelof STAT1 phosphorylation compared with TI stimula-
tion alone. Treatment with CSYJE showed a dramatic re-
duction in STAT1 phosphorylation in a dose-dependent
manner (Fig. 5a). Consistent with the results of western
blotting, immunofluorescence staining revealed that
CSYJE inhibited the TI-induced nuclear localization of
STAT1 in HaCaT cells (Fig. 5b).
Discussion
CSYJE, a traditional herbal fomula, is composed of 9
medicinal herbs such as Nelumbinis Semen, Poria
Sclerotium, Ginseng Radix, Astragali Radix, Scutellariae
Radix, Plantaginis Semen, Liriope Tuber, Lycii Radicis
Cortex, and Glycyrrhizae Radix et Rhizoma and has been
used to treat neuropsychiatric disease, stroke, renal
tuberculosis, stomatitis, pyelitis, and cystitis in Korea
[18]. The major components of the 9 herbal medicines
are known as follows: flavonoids (e.g. isoquercitrin and
quercetin-3-O-glucuronide) from Nelumbinis Semen
[14], triterpenoids (e.g. pachymic acid and dehydropa-
chymic acid) from Poria Sclerotium [19, 20], triterpe-
noids (e.g. ginsenoside Rb1 and Rb1) from Ginseng Radix
[21], flavonoids (e.g. formononetin and calycosin-7-O-glu-
coside) from Astragali Radix [22], flavonoids (e.g. baicalin
Fig. 5 Changes in TNF-α and IFN-γ-stimulated STAT1 phosphorylation in CSYJE-treated HaCaT cells. a The expression of STAT1 phosphorylation
was measured using cells cotreated with CSYJE, and TNF-α and IFN-γ (each 10 ng/mL, TI) for 24 h. Silymarin (12.5, or 25 μg/mL) was used as a
positive control. b Cellular localization of STAT1 was examined by immunofluorescence staining. Cells were co-treated with CSYJE (500 μg/mL), and
TI for 30 min. The cells were fixed in 4 % (v/v) methanol-free formaldehyde solution (pH 7.4), stained with anti-STAT1 (red). The stained cells were
mounted in medium containing DAPI (blue) and visualized under an Olympus FLUOVIEW FV 10i confocal microscope
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(e.g. genoiposide and genipsidic acid) form Plantaginis
Semen [24, 25], steroid saponins (e.g. spicatoside A and B)
form Liriope Tuber [26], phenylpropanoid (chlorogenic
acid) and flavonoid (e.g. rutin) form Liriope Tuber [27],
and triterpene saponin (e.g. glycyrrhizin) and flavonoids
(e.g. liquiritin and liquiritigenin), from Glycyrrhizae Radix
et Rhizoma [28]. Among those constituents, we tried to
analyze 19 compounds, such as hyperoside, isoquercitrin,
pachymic acid, ginsenoside Rb1, ginsenoside Rg1, formo-
nonetin, baicalin, baicalenin, wogonoside, wogonin, geni-
poside, geniposidic acid, spicatoside A, chlorogenic acid,
rutin, liquiritigenin, liquiritin, liquiritin apioside, and gly-
cyrrhizin using optimized HPLC–PDA method in CSYJE
sample. Consequently, the main components of Scutellar-
iae Radix Glycyrrhizae Radix et Rhizoma, liquiritin apio-
side, liquiritin, baicalin, wogonoside, and glycyrrhizin
were detected. However, other components were not de-
tected in this sample. Finally, baicalin (22.52 ± 0.36 mg/g),marker compound of Scutellariae Radix, was detected as
the major compound in CSYJE extract.
In the present study, we found that CSYJE inhibited
the actions of various inflammatory mediators. CSYJE
inhibited production of the pro-inflammatory mediators
NO and PGE2, and cytokine IL-6 in LPS-stimulated
macrophages. CSYJE also inhibited the production of
the chemokines TARC, MDC, RANTES, and IL-8, and
suppressed STAT1 activation in TI-treated keratinocytes.
Macrophages, as innate immune cells, initiate inflam-
mation and the immune response [29]. When challenged
with LPS, macrophages are activated and release various
pro-inflammatory factors, excessive release of which
can result in extensive tissue damage and pathological
changes. NO, an important cellular signaling molecule
and pro-inflammatory mediator produced by inducible
nitric oxide synthase (iNOS), plays a key role in the
pathogenesis of inflammation caused by its overproduction
in abnormal situations [30]. PGE2 is another important
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(COX-2). Its expression is elevated in LPS-stimulated
macrophages, and is associated with many chronic inflam-
matory diseases including cardiovascular diseases, arthritis,
inflammatory bowel disease, angiogenesis, and chronic
gastric ulcers [31–33]. Macrophages also release pro-
inflammatory cytokines including IL-1β, IL-6, and TNF-α,
which are used to evaluate potential anti-inflammatory
properties of agents against LPS-induced macrophage acti-
vation [34]. In the present study, CSYJE significantly
inhibited the concentrations of NO and PGE2 in the
supernatant in LPS-stimulated RAW 264.7 cells. Thus,
CSYJE might reduce inflammatory responses by inhibiting
IL-6 secretion.
Keratinocytes produce various chemokines, which are
involved in the development of inflammatory diseases.
TARC and MDC are produced by dendritic cells,
endothelial cell and keratinocytes which bind and attract
CCR4+ Th2 cells into inflammatory tissues [7]. Several
studies have reported that there are high levels of TARC
and MDC in the serum of patients with atopic dermatitis
[35]. The severity of atopic dermatitis was significantly
correlated with these chemokine levels [36]. RANTES is
overexpressed in the keratinocytes of such patients. In
addition, RANTES has a significant role in the inflamma-
tory process of psoriasis. Here, we found that CSYJE
inhibited TARC, MDC, RANTES, and IL-8 production in
TI-stimulated HaCaT keratinocytes.
STAT1 is also a pivotal regulator of IFN-γ-induced
immune responses [37]. The activated STAT1 pathway can
modulate the expression of numerous inflammatory medi-
ators, including chemokines [14]. Here we demonstrated
that CSYJE inhibited the TI-induced phosphorylation and
nuclear translocation of STAT1 in HaCaT cells. These data
suggest that CSYJE might block the induction of chemo-
kine production including TARC, MDC, and RANTES in
TI-treated keratinocytes by inhibiting STAT1 activation.
Conclusions
Our present study demonstrated that CSYJE inhibited the
levels of NO, PGE2, and IL-6 in LPS-stimulated RAW
264.7 cells, and reduced the production of chemokines
TARC, MDC, RANTES, and IL-8 by suppressing the acti-
vation of STAT1 in TI-stimulated HaCaT cells. Further
elucidation of the signaling pathways involved in the
inhibition of inflammatory mediators by CSYJE is now
needed to facilitate the design of therapeutic agents for
inflammatory diseases.
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